Bethany Stern
Family · Hazelwood, MONPI 1801331152
Payments from drug & device makers
Across 81 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$245
- Novo Nordisk$224
- Tolmar, Inc.$192
- Ascendis Pharma Endocrinology Inc$137
- Tris Pharma Inc$64
- Merck$63
- plus $723 from 21 others
What the payments were for
- Food & beverage$1,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $245 |
| Novo Nordisk | 12 | $224 |
| Tolmar, Inc. | 8 | $192 |
| Ascendis Pharma Endocrinology Inc | 7 | $137 |
| Tris Pharma Inc | 3 | $64 |
| Merck | 4 | $63 |
| GSK | 4 | $63 |
| Azurity Pharmaceuticals, Inc. | 3 | $56 |
| Dexcom, Inc. | 2 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $47 |
| Alk-abello, Inc | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $44 |
| Amphastar Pharmaceuticals, Inc. | 2 | $40 |
| BETA Bionics, Inc. | 2 | $40 |
| Corium, LLC | 2 | $40 |
| Neurelis, Inc. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Sobi, Inc | 1 | $32 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Phadia US Inc. | 1 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
How this compares
$1,648 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $10,980 |
| Wixela InhubFluticasone Propion/Salmeterol | 20 | $1,685 |
| Triamcinolone Acetonide | 48 | $687 |
| Prednisone | 167 | $443 |
| Metoprolol Succinate | 29 | $425 |
| Losartan Potassium | 42 | $382 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $308 |
| Gabapentin | 29 | $297 |
| Naproxen | 29 | $266 |
| Furosemide | 46 | $265 |
| Meclizine Hcl | 25 | $264 |
| Fluticasone Propionate | 35 | $261 |
| Atorvastatin Calcium | 19 | $236 |
| Spironolactone | 11 | $228 |
| Amlodipine Besylate | 44 | $218 |
Paid to pharmacies, not to this prescriber.
Other family in Hazelwood
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.